Strategic Expansion SciLifeLab operates as a national center with multiple sites across Stockholm, Uppsala, Lund, Gothenburg, Linköping and Umeå, highlighting opportunities to collaborate with regional institutes and clinical partners for funded translational research programs and joint grant proposals.

AI & Data Active work on training AI models with limited and heterogeneous data suggests potential for collaborations in AI-driven biomedical analytics, diagnostic support tools, and research platforms that require advanced machine learning methods.

Clinical Integration Recent partnerships with Karolinska Hospital and Karolinska Institutet to embed whole genome sequencing into routine diagnostics indicate a pathway for co-development of diagnostic pipelines, genomic testing services, and translational workflows.

Industry Partnerships Active collaborations with Pretzel Therapeutics and Alamar Biosciences demonstrate SciLifeLab’s appeal to biotechnology companies seeking access to cryo-EM capabilities and proteomics-driven biomarker discovery, signaling potential for sponsored research, contract development, and commercial licensing.

Funding & Visibility As a national research hub with government backing and high-profile science prizes, SciLifeLab offers opportunities to pitch joint funding initiatives, participate in science outreach partnerships, and leverage its reputation to attract sponsored research funding and industry co-investments.